Skip to main content
Clinical Trials/NCT06373107
NCT06373107
Terminated
Not Applicable

Investigating Effects of High-intensity Gait Training on Gait Function, Balance and Depression Following Stroke and the Impact of Social Determinants of Health and Depression on Patients' Adherence to Physical Therapy

Alvernia University1 site in 1 country3 target enrollmentDecember 1, 2024
ConditionsStroke

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Stroke
Sponsor
Alvernia University
Enrollment
3
Locations
1
Primary Endpoint
6-minute walk test
Status
Terminated
Last Updated
9 months ago

Overview

Brief Summary

The purpose of this research is to study the improvements from walking practice that is vigorous enough to keep participants' heart rate over a certain target level during their physical therapy sessions. The investigators want to know about improvements in participants' walking function and mental health after 20 interventions. The study also aims to evaluate if participants' mental health, social support, and health literacy affect their attendance at physical therapy sessions.

Detailed Description

The purpose of this research is to study the improvements from walking practice that is vigorous enough to keep participants' heart rate over a certain target level during their physical therapy sessions. The investigators want to know about improvement in participants' walking function and mental health after 20 interventions. The study also aims to evaluate if participants' mental health, social support, and health literacy affect their attendance at physical therapy sessions. The findings from this study will help the researchers and clinicians decide how to help people with stroke better. Further, the findings will determine how depressive symptoms, health literacy, and other factors such as language and education affect attendance to therapy. About 24 subjects will take part in this research.

Registry
clinicaltrials.gov
Start Date
December 1, 2024
End Date
May 30, 2025
Last Updated
9 months ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Soo Yeon Sun, PT, PhD

Associate Professor

Alvernia University

Eligibility Criteria

Inclusion Criteria

  • 18 years of age or older
  • English or Spanish speaking
  • A diagnosis of stroke (intracerebral hemorrhage or acute ischemic stroke)
  • Referred to LVHN Outpatient Neurologic Rehab (hereafter referred to as outpatient PT)

Exclusion Criteria

  • Unable to follow 1-step commands
  • \> 220 pounds (100 kg)
  • Height \< 5'0" or \> 6'4"
  • Unable to take a few steps with assistance
  • A score of ≥ 50/56 on Berg Balance Scale (BBS)
  • A score of ≥ 26/30 on Functional Gait Assessment (FGA)
  • Resting blood pressure \>180/110 mmHg
  • Resting heart rate \> 120 bpm
  • Severe cardiac disease (New York Heart Association Classification IV)
  • Severe spasticity (Modified Ashworth score \> 3)

Outcomes

Primary Outcomes

6-minute walk test

Time Frame: Pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)

Measures aerobic capacity and endurance

Berg Balance Scale

Time Frame: Pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)

a 14-item objective measure that assesses static balance and fall risk in adults. Berg balance scale scoring ranges from 0 to 56, with higher scores mean a better outcome.

Multidimensional Scale of Perceived Social Support (MSPSS)

Time Frame: Pre-intervention (baseline)

The MSPSS is a 12-item self-administered scale that measures social support. It contains 12-items, rated on a 7-point Likert-type scale, ranging from 1 "very strongly disagree" to 7 "very strongly agree." The scale was divided into 3 subscales: family, friends, and significant other, with each section consisting of 4 items. The response scale ranges from 12 to 84. Higher scores indicate a greater family social support.

10-meter walk test

Time Frame: Pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)

Measures forward gait velocity

Functional Gait Assessment

Time Frame: Pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)

This scale assess postural stability during walking and assesses an individual's ability to perform multiple motor tasks while walking. Scoring for each FGA item ranges from 0 for severe impairment to 3 for normal performance. The highest score possible is 30, with higher scores correlating better gait function.

Rate of patient attendance (Compliance) to physical therapy

Time Frame: Participant's attendance to physical therapy is tracked throughout the intervention sessions.

Greater than or equal to 80% attendance to physical therapy is considered compliance to physical therapy.

3-meter backwards walk test

Time Frame: Pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)

Measures backward gait velocity

Surface electromyography (EMG)

Time Frame: Pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)

Electromyographical recording of 8 leg muscles () is done during forward and backward walking tests.The EMG will be recorded during 3-meter Backward Walk Test, 6-minute Walk Test, and 10-meter Walk Test in all participants

Borg Rating Scale of Perceived Exertion (RPE)

Time Frame: Pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)

RPE is used to prescribe and monitor exercise intensity and correlates well with physiological measures of exercise intensity, including heart rate. The Borg Rating Scale of Perceived Exertion will be measured in all participants at the completion of 6 Minute Walk test. It ranges from 6 to 20, where 6 means "no exertion at all" and 20 means "maximal exertion." A lower score indicates a better exercise endurance.

Patient Health Questionnaire (PHQ-9)

Time Frame: Pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)

Depressive symptom questionnaire. As a severity measure, the PHQ-9 score can range from 0 to 27, since each of the 9 items can be scored from 0 (not at all) to 3 (nearly every day). A lower score indicates less depressive symptoms.

Newest Vital Sign

Time Frame: Pre-intervention (baseline)

The NVS is a 6-question screening tool that identifies participants' risk of low or limited health literacy based on interpreting an ice cream nutrition label. It is available from Pfizer Pharmaceutical Company. The level of health literacy for each individual will be categorized based on the scores: a score of 0-1 suggests a high likelihood of limited literacy, a score of 2-3 indicates the possibility of limited literacy, and a score of 4-6 almost always indicates adequate literacy. This categorical variable will be used to determine the association with adherence to physical therapy.

Study Sites (1)

Loading locations...

Similar Trials